Akari Minami

502 citations
14 papers · 383 indexed · h-index 10
Topics
PI3K/AKT/mTOR signaling in cancer (5 papers)Cancer Mechanisms and Therapy (2 papers)Alzheimer's disease research and treatments (2 papers)
Journals
SHILAP Revista de lepidopterologíaInternational Journal of Molecular SciencesFrontiers in Oncology
Partner nations
Japan

In The Last Decade

Akari Minami

14 papers receiving 377 citations

Peers

Akari Minami
Comparison fields: 5 of 76
  • Molecular Biology 201
  • Cancer Research 58
  • Genetics 52
  • Epidemiology 45
  • Physiology 43
Replace Amanda Knoten with:
Amanda Knoten United States
Ying-Tsen Tung Taiwan
Qi-Wen Guan China
Lingli Yan China
Tomotaka Yokoo Japan
Laura Gomez‐Virgilio Mexico
Nathalie Khoury United States
Danit Oz-Levi Israel
Guoda Ma China
Akari Minami relative to Amanda Knoten United States Amanda Knoten's profile →
Citations per field
00.5×2.8×
Amanda Knoten · 1×
Citations per year

Countries citing papers authored by Akari Minami

Since Specialization
Citations

This map shows the geographic impact of Akari Minami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akari Minami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akari Minami more than expected).

Fields of papers citing papers by Akari Minami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akari Minami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akari Minami. The network helps show where Akari Minami may publish in the future.

Co-authorship network of co-authors of Akari Minami

This figure shows the co-authorship network connecting the top 25 collaborators of Akari Minami. A scholar is included among the top collaborators of Akari Minami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akari Minami. Akari Minami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 2
2 77
3 33
4 13
5 41
6 4
7 33
8 30
9 82
10 9
11 30
12 11
13 5
14 13

About Akari Minami

Akari Minami is a scholar working on Geriatrics and Gerontology, Pharmacology and Neurology, having authored 14 papers that have together received 383 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer Mechanisms and Therapy (2 papers) and Alzheimer's disease research and treatments (2 papers). The work is most often cited by research in Cancer Research (58 citations), Biological Psychiatry (9 citations) and Neurology (29 citations). Akari Minami has collaborated with scholars based in Japan. Frequent co-authors include Yasuko Kitagishi, Satoru Matsuda, Yasunori Ogura, Atsuko Nakanishi, Noriko Nakano, Mayuko Ichimura‐Shimizu, Toshiyuki Murai, Miho Suzuki and Keiko Kobayashi. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026